Trial intelligence / Profile preview

Phase 3 study of KHK7580 in secondary hyperparathyroidism on peritoneal dialysis

jRCT2080222964Phase 3

Sponsor
Kyowa Kirin
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ASP7991 in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD), sponsored by Kyowa Kirin.

02

Drugs

ASP7991
03

Conditions

secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)

Beyond the preview

Go deeper on jRCT2080222964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call